賽托瑞醫療 CYTX 深 滬
已收盤 08-30 16:00:00 美东时间
0.2077
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.2077
- 總市值 376.46万
- 52周最高 14062.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3825.00
- 委 比 0.00%
- 總股本 1812.50万
- 歷史最高 13865625.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3825.00
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cerenome Launches as an Integrated CNS Oncology Company
Cerenome (formerly Plus Therapeutics) rebrands as an integrated CNS oncology company, combining precision diagnostics, targeted therapeutics, and AI to improve CNS cancer detection, treatment, and understanding. Effective August 3, 2026, the company will trade under the ticker symbol "CNSY." Its strategy centers on three platforms: CNSide® diagnostics, REYOBIQ™ radiotherapeutic, and an AI-driven data platform, aiming to enhance patient outcomes a...
07-31 12:30
Plus Therapeutics wins Elevance Health coverage deal
Plus Therapeutics (PSTV) shares rose in early premarket trading after its subsidiary CNSide Diagnostics announced an agreement with Elevance Health (ELV) to expand coverage for a cancer screening test...
06-25 20:02
Plus Therapeutics to Provide Business Update Call on June 30, 2026
Plus Therapeutics will host a business update conference call on June 30, 2026, at 8:30 a.m. ET, discussing progress on its CNS cancer diagnostics, lead drug Reyobiq, and integrated AI plans. CEO Marc H. Hedrick highlights advancements in diagnostics, therapeutics, and AI, aiming to improve outcomes for CNS oncology patients and deliver long-term value to shareholders. The call will also cover the CNSide diagnostic launch and the company's vision...
06-23 11:30
Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday
Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analyst ratings page.
06-08 21:52
Plus Therapeutics Launches New At-The-Market Equity Program
An announcement from Plus Therapeutics ( ($PSTV) ) is now available. On June 1,...
06-06 06:26
Plus Therapeutics Subsidiary's Clinical Laboratory Gets Accreditation From College Of American Pathologists
CNSide Diagnostics, LLC, a wholly owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company advancing precision diagnostics and radiopharmaceuticals for central nervous
06-04 19:32
